Global NASH Congress
February 26 - 27, 2018 - London UK
This two-day conference will facilitate collaboration between senior representatives from industry, hospitals, universities and regulators. Extended networking time and small group roundtable discussions will provide ample opportunity for idea sharing and cooperation between the stakeholders in attendance. 40+ speakers will present across topics such as molecular heterogeneity of NAFLDs in humans, lifestyle intervention, and autotaxin as a potential drug target for NASH. Additionally, the US FDA and European Medicines Agency will give regulatory talks.